Condition
Mammary Gland Hyperplasia
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Breast Reduction
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Unknown1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Breast Reduction1
- Rugdenzengsheng No 1 Prescription1
Active Sponsors
- Vastra Gotaland Region1
- Jiuda Zhao1
Top Investigators
Göteborg University